pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
PUBLIC COMPANY
save

$BCAXBicara Therapeutics Inc.

$BCAX24.63+3.66%
Boston, MA, USupdated 9h ago
Website ↗SEC EDGAR ↗Yahoo Finance ↗
community read0 votes
pipeline
1
marketed
0
phase 3
1
catalysts ytd
1
approvals ytd
0
recalls ytd
0

Pipeline(1)

pipeline depth1 products
Phase 3: 1
1Phase 3
Phase 3
ficerafusp alfa
Recurrent Head And Neck Squamous Cell Carcinoma

📅 Upcoming

no upcoming catalysts on record

🕒 Recent(90d)

earnings (1)
Aug 11, 2026
earnings
$BCAX24.63+3.66%
2d ago
Bicara Therapeutics Inc. earnings
Bicara Therapeutics Inc.
→
view all catalysts →

Active trials

  • phase3FORTIFI-HN01: A Study of Ficerafusp Alfa (BCA101) or Placebo in Combination With Pembrolizumab in First-Line PD-L1-pos, R or M HNSCCrecruitingn=650
  • phase1Study of Safety and Tolerability of BCA101 Monotherapy and in Combination Therapy in Patients With EGFR-driven Advanced Solid Tumorsrecruitingn=292

Insider activity

source: SEC Form 4

open-market buys + sells

  • Apr 21, 26SELLHyep Ivan· Chief Financial Officer9,200 sh @ $23.00−$212K↗
  • Apr 20, 26SELLMazumdar Claire· Chief Executive Officer15,000 sh @ $23.61−$354K↗
  • Apr 15, 26SELLCohlhepp Ryan· President and COO8,000 sh @ $23.01−$184K↗
  • Apr 15, 26SELLCohlhepp Ryan· President and COO4,500 sh @ $23.01−$104K↗
  • Mar 25, 26SELLRaben David· Chief Medical Officer5,500 sh @ $18.95−$104K↗
  • Mar 23, 26SELLHyep Ivan· Chief Financial Officer9,200 sh @ $18.52−$170K↗
  • Mar 20, 26SELLMazumdar Claire· Chief Executive Officer1,596 sh @ $18.95−$30K↗
  • Mar 19, 26SELLMazumdar Claire· Chief Executive Officer6,905 sh @ $18.78−$130K↗
  • Mar 18, 26SELLMazumdar Claire· Chief Executive Officer6,499 sh @ $18.84−$122K↗
  • Mar 16, 26SELLCohlhepp Ryan· President and COO8,000 sh @ $19.66−$157K↗
  • Mar 16, 26SELLCohlhepp Ryan· President and COO4,500 sh @ $19.66−$88K↗
  • Mar 9, 26SELLMazumdar Claire· Chief Executive Officer36,766 sh @ $19.17−$705K↗
  • Mar 6, 26SELLMazumdar Claire· Chief Executive Officer3,817 sh @ $18.75−$72K↗
  • Mar 5, 26SELLMazumdar Claire· Chief Executive Officer1,786 sh @ $18.74−$33K↗
  • Mar 4, 26SELLRaben David· Chief Medical Officer16,300 sh @ $18.52−$302K↗
  • Mar 4, 26SELLHyep Ivan· Chief Financial Officer2,963 sh @ $18.25−$54K↗
  • Mar 4, 26SELLMazumdar Claire· Chief Executive Officer2,631 sh @ $18.73−$49K↗
  • Mar 3, 26SELLHyep Ivan· Chief Financial Officer13,555 sh @ $18.22−$247K↗
  • Mar 3, 26SELLCohlhepp Ryan· President and COO12,892 sh @ $18.16−$234K↗
  • Mar 3, 26SELLCohlhepp Ryan· President and COO4,500 sh @ $18.16−$82K↗
🐶 Hiring Signal
No open roles indexed yet — view Bicara Therapeutics Inc. jobs →

News

no news has mentioned this company yet
identifiers
ticker
$BCAX
SEC CIK
0002023658
country
US
source
sec_tickers
top tags
Oncology1
mentioned in
0news items
entity-linker matched
Data sources
SEC EDGAR
last refreshed 7m ago
Found something off?
🐶 something off?

Report a data issue

Tell Bork what looks wrong — wrong sponsor, stale phase, mislinked ticker, anything. We’ll triage and fix.

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?